LeonaBio, Inc. (LONA) vs NextCure, Inc. (NXTC)
A side-by-side comparison of LeonaBio, Inc. and NextCure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LONA
LeonaBio, Inc.
$5.67HealthcareDelayed quote: Oct 6, 2026, 1:19 PM EDT
NXTC
NextCure, Inc.
$5.60HealthcareDelayed quote: Oct 6, 2026, 1:20 PM EDT
Total return — LONA vs NXTC
growth of $100 · dividends reinvested · last 6yLONA -96.7% (-43.5%/yr)NXTC -95.6% (-40.6%/yr)NXTC compounded faster over this window
LONA NXTC
LONA vs NXTC: by the numbers
- •LONA is the larger company ($22M vs $20M market cap).
Metrics side by side
Valuation
| Metric | LONA | NXTC |
|---|---|---|
| P/B ratio | 0.67 | 1.66 |
Profitability
| Metric | LONA | NXTC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -421.06% | -351.86% |
| ROIC | -248.21% | -259.91% |
Growth (annualized)
| Metric | LONA | NXTC |
|---|---|---|
| Total return CAGR (5Y) | -43.13% | -44.29% |
Frequently asked
- How have LONA and NXTC total returns compared?
- Over the past 5 years, LONA delivered -43.13% and NXTC delivered -44.29% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.